Medical News

RSS

Scientists discover how immune cells recognize invading pathogens in the body

Scientists at Cedars-Sinai Medical Center have discovered how a molecular receptor on the surface of white blood cells identifies when invading fungi have established direct contact with the cell surface and pose an infectious threat.

30 Apr 2011

Viewpoints: Suggestions for modifying proposals on Medicare

In recent weeks, our country has continued an important conversation about our fiscal future. Washington doesn't agree on much, but we all agree that we need to reduce our deficit and debt. Reforming Medicare and reducing health-care spending is crucial to meeting that goal. But there's a right way to reform Medicare and a wrong way.

30 Apr 2011

Visionary Healthware receives ONC-ATCB certification for new EHR solution

Visionary HealthWare, a CompuGroup Medical company, announced today that Alteer Office 8.0 is 2011/2012 compliant and was certified as a Complete EHR on 4/22/2011 by the Certification Commission for Health Information Technology, an ONC-ATCB, in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services.

30 Apr 2011

Gene therapy approach using CD59 shows promise against AMD: Study

A gene therapy approach using a protein called CD59, or protectin, shows promise in slowing the signs of age-related macular degeneration, according to a new in vivo study by researchers at Tufts University School of Medicine.

30 Apr 2011

AACN to present Flame of Excellence Award to Baylor cardiovascular nurse specialist

The American Association of Critical-Care Nurses will present the Flame of Excellence Award to Barbara "Bobbi" Leeper, RN, MN, CNS M-S, CCRN, FAHA, cardiovascular clinical nurse specialist at Baylor University Medical Center, Dallas.

30 Apr 2011

CEL-SCI receives no objection letter to initiate Phase III clinical trial of Multikine in Canada

CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.

30 Apr 2011

DVA is now DaVita Labs

Operating as a division of DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease and chronic kidney disease, DVA Laboratory Services announced its new company name, DaVita Labs.

30 Apr 2011

Black cardiac arrest victims less apt to survive at hospitals: Study

Black cardiac arrest victims are more likely to die when they're treated in hospitals that care for a large black population than when they're brought to hospitals with a greater proportion of white patients, according to new research from the University of Pennsylvania School of Medicine.

30 Apr 2011

Aptilon annual revenue increases 111% to $33.5 million

Aptilon Corporation, a leader in online access, engagement and interaction with physicians and healthcare professionals on behalf of pharmaceutical and life sciences companies, today announced its financial results for the year ended December 31, 2010.

30 Apr 2011

Mary Ann Liebert introduces new videojournal on minimally invasive surgery

Videoscopy-, a groundbreaking new videojournal to complement the peer-reviewed monthly publication, Journal of Laparoendoscopic & Advanced Surgical Techniques has been launched by Mary Ann Liebert, Inc., publishers.

30 Apr 2011

HHS launches Hospital Value-Based Purchasing program

The Department of Health and Human Services today launched a new initiative which will reward hospitals for the quality of care they provide to people with Medicare and help reduce health care costs.

30 Apr 2011

Magellan reports net revenue of $692.8 million for first quarter 2011

Magellan Health Services, Inc. today reported financial results for the first quarter of 2011, as summarized below, and increased guidance for the full year.

30 Apr 2011

FDA approves Abbott's AndroGel for hypogonadism treatment in men

Abbott announced today that the U.S. Food and Drug Administration has approved AndroGel 1.62%, a clear, odorless, gel formulation shown to restore testosterone levels in hypogonadal men with half the volume of gel at the starting dose compared to AndroGel 1%.

30 Apr 2011

Noveko closes private placement for $595,104

Noveko International Inc. announces a first closing of $595,104 of its private placement. Additional closings are expected until May 23, 2011.

30 Apr 2011

Spectrum receives FDA approval for FUSILEV to treat colorectal cancer

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, received approval from the U.S. Food and Drug Administration on April 29, 2011, for the use of FUSILEV in combination with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer.

30 Apr 2011

HMS first quarter revenue increases 27% to $82.5 million

HMS Holdings Corp. Reports Record First Quarter 2011 Results

30 Apr 2011

Reimbursement policy influences choice of IMRT for treating breast cancer

What Medicare would pay for and where a radiation oncologist practiced were two factors that strongly influenced the choice of intensity-modulated radiation therapy (IMRT) for treating breast cancer, according to an article published April 29 online in the Journal of the National Cancer Institute. The use of IMRT and the cost of radiation therapy increased sharply over the period of the study.

29 Apr 2011

Oncothyreon prices underwritten public offering of common stock

Oncothyreon Inc. today announced that it has priced an underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $4.00 per share for gross proceeds of $40.0 million. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses payable by Oncothyreon, will be approximately $37.4 million.

29 Apr 2011

Annual mammogram sufficient follow-up after BCT for breast cancer patients

An annual mammogram is sufficient follow-up after breast conserving therapy (BCT) for breast cancer patients, according to a study presented today, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. This symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and Radiological Society of North America (RSNA).

29 Apr 2011